ABT vs CECO · P/E 25, rev $44.33B vs P/E 249, rev $490.9M
Abbott Laboratories (ABT) versus CECO Environmental Corp. (CECO) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
CECO Environmental Corp. (CECO) is a pollution & treatment controls company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported CECO revenue for 2026-06-30 was $490.9M. Net income was -$35.2M. CECO currently screens at market cap $3.39B and trailing P/E 248.6.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. CECO currently screens at market cap $3.39B and trailing P/E 248.6.
Not investment advice. Open the ABT and CECO stock pages for the full models.
Not investment advice.